SHC3
SHC-transforming protein 3
Also known as: N-Shc, NSHC, SHC3_HUMAN, SHCC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92529
- Gene
- SHC3
- Ensembl
- ENSG00000148082
- Chromosome
- 9
- Canonical length
- 594 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables phosphotyrosine residue binding activity. Predicted to be involved in cell surface receptor protein tyrosine kinase signaling pathway. Predicted to act upstream of or within glutamatergic synaptic transmission and learning or memory. Predicted to be located in cytosol. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
594 residues, UniProt reviewed canonical sequence.
>Q92529|SHC3
1 MLPRTKYNRF RNDSVTSVDD LLHSLSVSGG GGKVSAARAT PAAAPYLVSG EALRKAPDDG
61 PGSLGHLLHK VSHLKLSSSG LRGLSSAARE RAGARLSGSC SAPSLAAPDG SAPSAPRAPA
121 MSAARKGRPG DEPLPRPPRG APHASDQVLG PGVTYVVKYL GCIEVLRSMR SLDFSTRTQI
181 TREAISRVCE AVPGAKGAFK KRKPPSKMLS SILGKSNLQF AGMSISLTIS TASLNLRTPD
241 SKQIIANHHM RSISFASGGD PDTTDYVAYV AKDPVNRRAC HILECCDGLA QDVIGSIGQA
301 FELRFKQYLQ CPTKIPALHD RMQSLDEPWT EEEGDGSDHP YYNSIPSKMP PPGGFLDTRL
361 KPRPHAPDTA QFAGKEQTYY QGRHLGDTFG EDWQQTPLRQ GSSDIYSTPE GKLHVAPTGE
421 APTYVNTQQI PPQAWPAAVS SAESSPRKDL FDMKPFEDAL KNQPLGPVLS KAASVECISP
481 VSPRAPDAKM LEELQAETWY QGEMSRKEAE GLLEKDGDFL VRKSTTNPGS FVLTGMHNGQ
541 AKHLLLVDPE GTIRTKDRVF DSISHLINHH LESSLPIVSA GSELCLQQPV ERKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SHC3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 40 nTPM
- amygdala: 23 nTPM
- hippocampal formation: 20 nTPM
- basal ganglia: 16 nTPM
- hypothalamus: 10 nTPM
- adrenal gland: 8.7 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 474 nCPM
- adrenal cortex cells: 433 nCPM
- brain inhibitory neurons: 134 nCPM
- distal convoluted tubule cells: 114 nCPM
- brain excitatory neurons: 113 nCPM
- alveolar cells type 2: 93 nCPM
Immune cell
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 107 nTPM
- basal ganglia: 94 nTPM
- amygdala: 73 nTPM
- hippocampal formation: 71 nTPM
- white matter: 71 nTPM
- hypothalamus: 50 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.54
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 1.4
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor protein tyrosine kinase signaling pathway
- central nervous system development
- epidermal growth factor receptor signaling pathway
- intracellular signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SHC3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SHC3 as an antibody target. Whether an autoantibody or antibody against SHC3 could matter depends on whether native SHC3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SHC3 is annotated at the cell surface, where native SHC3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SHC3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...